GRAMD1B
Protein Aster-B
Also known as: ASTRB_HUMAN, KIAA1201, LINC01059
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q3KR37
- Gene
- GRAMD1B
- Ensembl
- ENSG00000023171
- Chromosome
- 11
- Canonical length
- 738 aa
- Protein class
- Predicted intracellular proteins, Predicted membrane proteins, Transporters
- Subcellular location
- Endoplasmic reticulum,Vesicles,Plasma membrane
OverviewNCBI Gene
Predicted to enable cholesterol binding activity; cholesterol transfer activity; and phospholipid binding activity. Predicted to be involved in cellular response to cholesterol; cholesterol homeostasis; and intracellular sterol transport. Located in endoplasmic reticulum membrane; endoplasmic reticulum-plasma membrane contact site; and plasma membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
738 residues, UniProt reviewed canonical sequence.
>Q3KR37|GRAMD1B
1 MKGFKLSCTA SNSNRSTPAC SPILRKRSRS PTPQNQDGDT MVEKGSDHSS DKSPSTPEQG
61 VQRSCSSQSG RSGGKNSKKS QSWYNVLSPT YKQRNEDFRK LFKQLPDTER LIVDYSCALQ
121 RDILLQGRLY LSENWICFYS NIFRWETLLT VRLKDICSMT KEKTARLIPN AIQVCTDSEK
181 HFFTSFGARD RTYMMMFRLW QNALLEKPLC PKELWHFVHQ CYGNELGLTS DDEDYVPPDD
241 DFNTMGYCEE IPVEENEVND SSSKSSIETK PDASPQLPKK SITNSTLTST GSSEAPVSFD
301 GLPLEEEALE GDGSLEKELA IDNIMGEKIE MIAPVNSPSL DFNDNEDIPT ELSDSSDTHD
361 EGEVQAFYED LSGRQYVNEV FNFSVDKLYD LLFTNSPFQR DFMEQRRFSD IIFHPWKKEE
421 NGNQSRVILY TITLTNPLAP KTATVRETQT MYKASQESEC YVIDAEVLTH DVPYHDYFYT
481 INRYTLTRVA RNKSRLRVST ELRYRKQPWG LVKTFIEKNF WSGLEDYFRH LESELAKTES
541 TYLAEMHRQS PKEKASKTTT VRRRKRPHAH LRVPHLEEVM SPVTTPTDED VGHRIKHVAG
601 STQTRHIPED TPNGFHLQSV SKLLLVISCV ICFSLVLLVI LNMMLFYKLW MLEYTTQTLT
661 AWQGLRLQER LPQSQTEWAQ LLESQQKYHD TELQKWREII KSSVMLLDQM KDSLINLQNG
721 IRSRDYTSES EEKRNRYHLocalizationUniProt · AlphaFold · HPA
Whether an antibody against GRAMD1B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 204 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 204 nTPM
- cerebellum: 112 nTPM
- retina: 89 nTPM
- cerebral cortex: 37 nTPM
- choroid plexus: 35 nTPM
- duodenum: 29 nTPM
Single-cell type
- cone photoreceptor cells: 1,246 nCPM
- adrenal cortex cells: 1,196 nCPM
- proximal tubule cells: 976 nCPM
- choroid plexus epithelial cells: 913 nCPM
- rod photoreceptor cells: 765 nCPM
- distal convoluted tubule cells: 605 nCPM
Immune cell
- plasmacytoid DC: 6.8 nTPM
- myeloid DC: 1.6 nTPM
- NK-cell: 1.6 nTPM
- memory CD4 T-cell: 1.5 nTPM
- memory CD8 T-cell: 1.2 nTPM
- classical monocyte: 1.1 nTPM
Brain region
- choroid plexus: 204 nTPM
- cerebellum: 201 nTPM
- cerebral cortex: 145 nTPM
- hippocampal formation: 143 nTPM
- thalamus: 104 nTPM
- pons: 92 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about GRAMD1B.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 111 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 3.23
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of GRAMD1B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads GRAMD1B as an antibody target. Whether an autoantibody or antibody against GRAMD1B could matter depends on whether native GRAMD1B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
GRAMD1B is annotated at the cell surface, where native GRAMD1B is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label GRAMD1B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...